$ENZ to $2.94 LONG - Monthly setup is strong

NYSE:ENZ   Enzo Biochem, Inc
3/16/23 - Enzo Biochem (ENZ) stock is rising higher on an asset sale agreement.
It’s selling its Clinical Laboratory division to Labcorp (LH).

3/20/23 - Monthly GD on MC.

8/23/23 - $3 per share.

*not financial advice

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.